dr. tolaney on trials investigating cabozantinib in breast cancer
Published 11 years ago • 417 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
2:06
dr. tolaney on the apt and atempt trials in stage i her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:32
dr tolaney on data with checkpoint inhibitor combinations in metastatic tnbc
-
2:46
sara tolaney, esmo 2022: clinical trial highlights in breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
1:24
dr. tolaney discusses pertuzumab in her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
0:55
dr. chan on trial of cabozantinib in neuroendocrine tumors
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
2:02
dr. tolaney on sequencing questions in breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc